Optimizing Boron Neutron Capture Therapy (BNCT) to Treat Cancer: An Updated Review on the Latest Developments on Boron Compounds and Strategies
Оптимизация бор-нейтронозахватной терапии (БНЗТ) для лечения рака: обновленный обзор последних разработок борсодержащих соединений и стратегий
2023-08-14
SCID: 54.1/9md32zd2
Discuss with AI
boron compoundsboron neutron capture therapyhospital-based acceleratorsradiobiological studiestheranostic boron agents
Figures from the paper
Abstract (AI)
Boron neutron capture therapy (BNCT) is a tumor-selective particle radiotherapy. It combines preferential boron accumulation in tumors and neutron irradiation. The recent initiation of BNCT clinical trials employing hospital-based accelerators rather than nuclear reactors as the neutron source will conceivably pave the way for new and more numerous clinical trials, leading up to much-needed randomized trials. In this context, it would be interesting to consider the implementation of new boron compounds and strategies that will significantly optimize BNCT. With this aim in mind, we analyzed, in this review, those articles published between 2020 and 2023 reporting new boron compounds and strategies that were proved therapeutically useful in in vitro and/or in vivo radiobiological studies, a critical step for translation to a clinical setting. We also explored new pathologies that could potentially be treated with BNCT and newly developed theranostic boron agents. All these radiobiological advances intend to solve those limitations and questions that arise during patient treatment in the clinical field, with BNCT and other therapies. In this sense, active communication between clinicians, radiobiologists, and all disciplines will improve BNCT for cancer patients, in a cost- and time-effective way.
Key Findings
1
Hospital-based accelerator neutron sources are enabling new BNCT clinical trials beyond reactor-based facilities and may support future randomized trials.
2
Recent developments include potential BNCT applications for additional cancer pathologies and newly developed theranostic boron agents.
3
The review emphasizes active collaboration among clinicians, radiobiologists, and other disciplines to improve BNCT efficiently for cancer patients.
4
The review identifies boron compounds and treatment strategies published from 2020–2023 that demonstrated therapeutic utility in vitro and/or in vivo radiobiological studies.
5
These advances aim to address limitations and unresolved clinical-treatment challenges, supporting BNCT translation and optimization.
Research Object
Boron neutron capture therapy (BNCT) for cancer treatment, including its boron compounds, therapeutic strategies, and potential target pathologies
Research Subject
Recent therapeutic optimization of BNCT through new boron compounds, treatment strategies, applications to additional pathologies, and theranostic boron agents
Publication Details
Publication Date
2023-08-14
Journal
Publisher
ISSN
Cited by
121
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest